ILLUMINA, INC.
ILMN · XNASCIK 1110803fmd_0HZ4ZZWX36BQ1QXQEPZX5KQBK9Manufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Dec 31, 2007 to Sep 27, 2026, 71 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 2,398 | 2,752 | 3,333 | 3,543 | 3,239 | 4,526 | 4,584 | 4,504 | 4,372 | 4,343 |
| Cost of revenue | 732 | 926 | 1,033 | 1,076 | 1,036 | 1,372 | 1,612 | 1,760 | 1,511 | 1,473 |
| Gross profit | 1,666 | 1,826 | 2,300 | 2,467 | 2,203 | 3,154 | 2,972 | 2,744 | 2,861 | 2,870 |
| Realized investment gains (losses) | – | – | – | 0 | 0 | 899 | 0 | 0 | – | – |
| Research and development | 504 | 546 | 623 | 647 | 682 | 1,185 | 1,321 | 1,354 | 1,169 | 967 |
| Selling, general and administrative | 584 | 674 | 794 | 835 | 941 | 2,092 | 1,297 | 1,612 | 1,092 | 1,086 |
| Total operating expenses | 1,079 | 1,220 | 1,417 | 1,482 | 1,623 | 3,277 | 7,151 | 3,813 | 3,694 | 2,063 |
| Operating income | 587 | 606 | 883 | 985 | 580 | (123) | (4,179) | (1,069) | (833) | 807 |
| Interest expense | 33 | 37 | 57 | 52 | 49 | 61 | 26 | 77 | 100 | 101 |
| Interest and investment income | 10 | 19 | 44 | 75 | 41 | 0 | 11 | 58 | 46 | 40 |
| Other non-operating income (expense) | (26) | 437 | 11 | 133 | 276 | 1,007 | (157) | (48) | (346) | 279 |
| Income before taxes | 561 | 1,043 | 894 | 1,118 | 856 | 884 | (4,336) | (1,117) | (1,179) | 1,086 |
| Income tax expense | 133 | 365 | 112 | 128 | 200 | 122 | 68 | 44 | 44 | 236 |
| Net income from continuing operations | 428 | 678 | 782 | 990 | 656 | 762 | (4,404) | (1,161) | (1,223) | 850 |
| Net income | 463 | 726 | 826 | 1,002 | 656 | 762 | (4,404) | (1,161) | (1,223) | 850 |